Token 2049’s Spotlight: Asia Leads the Race for the First DeSci Unicorn 1-10-2024, 16:23

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brai 18-09-2024, 22:07

Constellation Brands to Present at the 2025 Goldman Sachs Global Staples Forum on May 13, 2025 2-05-2025, 03:30